Abionyx Pharma SA (ABNX) — Cash Flow Quality Index
Abionyx Pharma SA (ABNX) has a Cash Flow Quality Index of -1.02x as of June 2019. Operating cash flow of €-2.96 Million is below net income of €2.90 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Abionyx Pharma SA operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Abionyx Pharma SA Cash Flow Quality Index (2019–2019)
Historical Cash Flow Quality Index for Abionyx Pharma SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Abionyx Pharma SA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Abionyx Pharma SA (2019–2019)
Year-by-year earnings quality comparison for Abionyx Pharma SA. For live market cap and the full company financial profile, see ABNX market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | -2.14x | €-3.95 Million | €1.85 Million | — |